Asenapine Sublingual Tablets (Saphris®)

Elliott, William T.; Chan, James
October 2009
Internal Medicine Alert;10/29/2009, Vol. 31 Issue 20, p157
The article offers updates on the approval of the sublingual tablet Asenapine by the U.S. Food and Drug Administration and marketed by the Schering-Plough Corp. for treating an acute schizophrenia, manic, or mixed episodes linked with bipolar disease in adults with minimal weight gain advantage.


Related Articles

  • News Briefs.  // American Journal of Health-System Pharmacy;9/15/2010, Vol. 67 Issue 18, p1499 

    The article reports that the U.S. Food and Drug Administration (FDA) has approved a new formulation of docetaxel and a needleless intravenous (i.v.) connector with chlorhexidine and silver and zero-fluid displacement.

  • Slew of approvables.  // Drug Topics;11/17/2003, Vol. 147 Issue 22, p27 

    Lists several approval drugs by the U.S. Food and Drug Administration. Ranexa to treat chronic angina; Insulin determir, a long-acting form of the diabetes drug; Fortament, an extended-release product to lower blood glucose.

  • FDA actions in brief.  // Formulary;Feb2010, Vol. 45 Issue 2, p42 

    The article discusses news briefs about drugs approved by the U.S. Food and Drug Administration (FDA). The drugs include dalfampridine extended release tablets, tocilzumab and morphine sulfate oral solution.

  • Pipeline preview.  // Formulary;Apr2010, Vol. 45 Issue 4, p113 

    The article offers U.S. Food & Drug Administration (FDA) drug approval news briefs. Miglustat has been approved for the treatment of Niemann-Pick type C disease, pirfenidone has been recommended for approval to improve lung function and pixantrone has been recommended not to be approved.

  • FDA actions in brief.  // Formulary;Apr2010, Vol. 45 Issue 4, p114 

    The article presents a list of drugs approved by the U.S. Food & Drug Administration (FDA) including doxepin for the treatment of insomnia, adapalene lotion for the treatment of acne and somatropin injection for the treatment of growth hormone disorders.

  • New molecular entities/biologics.  // Formulary;Feb2003, Vol. 38 Issue 2, p78 

    Reports on drugs approved by the U.S. Food and Drug Administration as of February 2003. Extraneal; Humira.

  • FDA Drug Approvals.  // Formulary;Jul2003, Vol. 38 Issue 7, p392 

    Reports on the U.S. Food and Drug Administration's approval of various drugs, as of July 2003. Boniva; Xolair; FluMist.

  • Pipeline preview.  // Formulary;Oct2009, Vol. 44 Issue 10, p290 

    The article lists various drugs approved by the U.S. Food and Drug Administration, including carisbamate, doxorubicin, and romidepsin.

  • FDA approves lipidatrophy drug.  // AIDS Alert;Mar2007, Vol. 22 Issue 3, p31 

    The article reports on the decision of the U.S. Food and Drug Administration to approve the lipidatrophy drug Radiesse.

  • FDA grants tentative approval of generic efavirenz.  // AIDS Alert;Mar2007, Vol. 22 Issue 3, p32 

    The article reports on the tentative approval granted by the U.S. Food and Drug Administration for the efavirenz capsules manufactured by Aurobindo Pharma Ltd. Inc.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics